Silk Road Medical Inc (SILK)’s Market Momentum: Closing Strong at 21.06, Up 1.10

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Silk Road Medical Inc’s stock clocked out at $21.06, up 1.10% from its previous closing price of $20.83. In other words, the price has increased by $1.10 from its previous closing price. On the day, 0.8 million shares were traded. SILK stock price reached its highest trading level at $21.37 during the session, while it also had its lowest trading level at $20.53.

Ratios:

To gain a deeper understanding of SILK’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.62 and its Current Ratio is at 11.05. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.56.

On January 19, 2024, Stifel Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $9 to $20.

On January 03, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $20.Lake Street initiated its Buy rating on January 03, 2024, with a $20 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 05 ’24 when Ballinger Kevin J. bought 11,700 shares for $16.99 per share. The transaction valued at 198,783 led to the insider holds 17,807 shares of the business.

Buchanan Lucas W. sold 9,877 shares of SILK for $169,578 on Mar 05 ’24. The COO/CFO now owns 500,925 shares after completing the transaction at $17.17 per share. On Mar 05 ’24, another insider, Davis Andrew S., who serves as the Chief Commercial Officer of the company, sold 5,481 shares for $17.17 each. As a result, the insider received 94,103 and left with 287,773 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SILK now has a Market Capitalization of 830688512 and an Enterprise Value of 740780864. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.48 while its Price-to-Book (P/B) ratio in mrq is 5.64. Its current Enterprise Value per Revenue stands at 3.994 whereas that against EBITDA is -13.554.

Stock Price History:

Over the past 52 weeks, SILK has reached a high of $34.13, while it has fallen to a 52-week low of $6.08. The 50-Day Moving Average of the stock is 7.17%, while the 200-Day Moving Average is calculated to be 40.12%.

Shares Statistics:

It appears that SILK traded 608.69K shares on average per day over the past three months and 729950 shares per day over the past ten days. A total of 39.17M shares are outstanding, with a floating share count of 35.81M. Insiders hold about 9.21% of the company’s shares, while institutions hold 103.74% stake in the company. Shares short for SILK as of 1715731200 were 3434813 with a Short Ratio of 5.64, compared to 1713139200 on 4138261. Therefore, it implies a Short% of Shares Outstanding of 3434813 and a Short% of Float of 9.87.

Most Popular